RT Journal Article
T1 Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain.
A1 Rodriguez Del Rio, Pablo
A1 Caimmi, Davide
A1 Rico, Pilar
A1 Vidal, Carmen
A1 Carmen, Moreno
A1 Pintoiu, Ileana M
A1 Beitia Mazuecos, Jose M
A1 Gonzalez de Olano, David
A1 Cuesta Alvaro, Pedro
A1 Demoly, Pascal
A1 Calderon, Moises A
K1 Anti-allergic agents
K1 COVID-19
K1 Desensitization, immunologic
K1 France
AB The COVID-19 pandemic represents a global health crisis and a challenge at all societal, economic and health levels. With the first cases having been reported in most of the European countries in January 2020,1  it was not until March that the pandemic hit the territory and lead to an unprecedent hard lock-down in most countries.
PB Wiley
YR 2021
FD 2021-11-04
LK http://hdl.handle.net/10668/19923
UL http://hdl.handle.net/10668/19923
LA en
NO Rodriguez Del Rio P, Caimmi D, Rico P, Vidal C, Carmen M, Pintoiu IM, et al. Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain. Clin Exp Allergy. 2022 Jan;52(1):167-170
DS RISalud
RD Apr 20, 2025